<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4620">
  <stage>Registered</stage>
  <submitdate>9/09/2013</submitdate>
  <approvaldate>9/09/2013</approvaldate>
  <nctid>NCT01949129</nctid>
  <trial_identification>
    <studytitle>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</studytitle>
    <scientifictitle>Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>ALL SCTped FORUM 2012</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute Lymphoblastic Leukaemia</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Leukaemia - Acute leukaemia</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Leukaemia - Chronic leukaemia</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Children's - Leukaemia &amp; Lymphoma</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - VP16
Treatment: other - TBI
Treatment: drugs - Thiotepa
Treatment: drugs - Treosulfan
Treatment: drugs - Fludarabine
Treatment: drugs - Busulfan

Experimental: conditioning Flu/Thio/Treo or Flu/Thio/ivBu - patients &gt; 4 years with a MSD or MD

Active Comparator: conditioning TBI/VP16 - VP16: 60 mg/kg, 1 day TBI: 12 Gray in 6 fractions over 3 days patients &gt; 4 years with MSD and MD

Other: for mismatched donor (MMD) transplantation - patients with mmd cordblood: Flu/Thio/Treo/ATG fres. or Alemtuzumab with haploidentical tx: Flu/Thio/Treo/ATG fres. or Alemtuzumab with mmd bm or pbsc:Flu/Thio/Treo or ivBU according country's decision


Treatment: drugs: VP16
60 mg/kg, administration: 1 day

Treatment: other: TBI
12 Gy in 6 fractions over 3 days

Treatment: drugs: Thiotepa
2x5 mg/kg, 1 day

Treatment: drugs: Treosulfan
14g/m² BS, 3 days

Treatment: drugs: Fludarabine
30 mg/m² BS, 5 days

Treatment: drugs: Busulfan
iV, dosage according therapeutic drug monitoring, 4 days

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Treatment: other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Overall Survival (OS) Stratum 1 (randomisation TBI+ chemo-conditioning vs. chemo-conditioning only)</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Event free survival (EFS) Stratum 2 (mismatched donor transplantation)</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>EFS (Stratum 1)</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cumulative Incidence of Treatment-related mortality (TRM) for Stratum 1 and 2</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cumulative Incidence of Relapse for Stratum 1 and 2</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>acute and late toxicity for Stratum 1 and 2 - according a preselection out of CTC3</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>OS (Stratum 2)</outcome>
      <timepoint>first: 18 months after inclusion of first patient, afterwards annually up to 10 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with ALL (except for patients with B-ALL) who fulfil the following criteria:

          -  age at time of screening less than 18 years

          -  indication for allogeneic HSCT

          -  complete remission (CR) before HSCT

          -  written consent of the parents (legal guardian) and, if necessary, the minor patient
             via "Informed Consent Form"

          -  no pregnancy

          -  no secondary malignancy

          -  no previous HSCT

          -  HSCT is performed in a study participating centre</inclusivecriteria>
    <inclusiveminage>6</inclusiveminage>
    <inclusiveminagetype>Months</inclusiveminagetype>
    <inclusivemaxage>18</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients who do not fulfil the inclusion criteria

          -  Non Hodgkin-Lymphoma

          -  ALL with extramedullary involvement with indication for TBI

          -  CNS involvement at the timepoint of screening

          -  Trisomy 21

          -  The whole protocol or essential parts are declined either by patient himself/herself
             or the respective legal guardian

          -  No consent is given for saving and propagation of anonymous medical data for study
             reasons

          -  Severe concomitant disease that does not allow treatment according to the protocol at
             the investigator's discretion (e.g. malformation syndromes, cardiac malformations,
             metabolic disorders)

          -  Karnofsky / Lansky score &lt; 50%

          -  Subjects unwilling or unable to comply with the study procedures</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2/Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/04/2023</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Royal Children's Hospital Queensland Children's Cancer Centre - Herston</hospital>
    <hospital>Children's Cancer Centre The Royal Children's Hospital - Parkville, Melbourne</hospital>
    <hospital>Princess Margaret Hospital for Children - Perth</hospital>
    <hospital>Sydney Children's Hospital - Randwick</hospital>
    <hospital>The Children`s Hospital at Westmead Oncology Unit - Sydney</hospital>
    <postcode>4029 - Herston</postcode>
    <postcode>3052 - Parkville, Melbourne</postcode>
    <postcode>6008 - Perth</postcode>
    <postcode>2031 - Randwick</postcode>
    <postcode>2145 - Sydney</postcode>
    <countryoutsideaustralia>
      <country>Argentina</country>
      <state>La Plata</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Graz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Innsbruck</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Austria</country>
      <state>Vienna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Brussels</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Gent</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Leuven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Alberta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Manitoba</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czech Republic</country>
      <state>Prague</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Copenhagen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Helsinki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>Turku</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Bordeaux</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Clermont-Ferrand</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Lille</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Lyon</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Marseille</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Montpellier</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Nancy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Nantes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Paris</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Rennes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Rouen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Strasbourg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Aachen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Berlin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Bonn</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Düsseldorf</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Erlangen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Essen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Frankfurt am Main</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Freiburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Gießen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Greifswald</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Halle</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Hamburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Hannover</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Heidelberg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Jena</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Kiel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Leipzig</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>München</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Münster</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Regensburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Tübingen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Ulm</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Germany</country>
      <state>Würzburg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Greece</country>
      <state>Athens</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Hungary</country>
      <state>Budapest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Haifa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Petach-Tikva</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Israel</country>
      <state>Tel Aviv</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Bologna</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Florence</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Genoa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Monza</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Padova</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Pavia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Pisa</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Rome</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Torino</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Trieste</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Leiden</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Utrecht</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Oslo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Slovakia</country>
      <state>Bratislava</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Göteborg</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Lund</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Stockholm</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Uppsala</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Basel</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Geneva</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>Zurich</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Ankara</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Antalya</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Istanbul</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Izmir</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Kayseri</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Samsun</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>St. Anna Kinderkrebsforschung</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>ALL SCTped Forum</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The ALL SCTped 2012 FORUM is a multinational, multi-centre, randomized, controlled,
      prospective seamless phase II/III study for the therapy and therapy optimisation for children
      and adolescents with ALL in CR, who have an indication for HSCT (hematopoetic stem cell
      transplantation) with a myeloablative conditioning regimen.

      The stratification and randomisation of patients in first and following remission according
      to the individual transplantation modalities rests upon an indication for allogeneic HSCT AND
      on the availability of a suitable donor within the individual transplantation groups.

      Main objectives - Objective 1: Randomisation of TBI vs non-TBI conditioning regimen for
      patients with a HLA matched-sibling donor or unrelated HLA matched donor.

      We aim at showing that a non-total body irradiation (TBI) containing conditioning
      (Flu/Thio/ivBu or Flu/Thio/Treo) results in a non-inferior survival as compared to
      conditioning with TBI/Etoposide in children older than 4 years after HSCT from a Human
      leucocyte antigen (HLA) identical sibling donor (MSD) or a HLA matched donor (MD).

      - Objective 2: Stratification of patients with a HLA mismatched donor according to stem cell
      source.

      We aim at exploring event free survival (EFS) after HSCT from HLA mismatched donors using
      mismatched unrelated donors (MMD), mismatched cord blood or HLA haplo-identical family
      members with non TBI-conditioning regimen.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01949129</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Christina Peters, Prof. MD PhD</name>
      <address>St. Anna Kinderspital, Vienna, Austria</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Christina Peters, Prof. MD PhD</name>
      <address />
      <phone>+43140170</phone>
      <fax />
      <email>christina.peters@stanna.at</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>